Generate a tailored SOP for Dr. Melissa Spencer. Improve your application with a focused, well-structured draft.
Dr. Melissa Spencer's lab focuses on gaining insight into the pathogenic mechanisms that occur in muscular dystrophies while identifying therapeutic interventions. Her research addresses critical questions regarding the immune system's contribution to Duchenne muscular dystrophy (DMD). Over the years, her work has identified osteopontin as a modulator of inflammation and fibrosis in DMD. Osteopontin is also a regulator of cell migration and plays a role in cancer cell metastases. In 2007, Spencer co-founded the Center for Duchenne Muscular Dystrophy (CDMD) at UCLA, alongside Drs. Carrie Miceli and Stanley Nelson. The center acts as a translational research platform, supporting both basic and clinical research initiatives, funded through various avenues including the National Institutes of Health (NIAMS), the Department of Defense, and several non-profit organizations. CDMD fosters collaboration, sharing of research ideas, and provides a supportive training environment for students and post-doc scholars.
University of California, Los Angeles • Los Angeles, CA
Professor in the Department of Neurology, focusing on research related to muscular dystrophies.
Department of Economics admits primarily for the PhD program.